Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Company type

    Small molecule drugs for pain and obesity. Aquired by Biovitrum AB in April 2005.

    Funding rounds

    (21 Mar 2005)

    Profile Country Notes
    Swedish Orphan Biovitrum AB Swedish pharmaceutical company with a product portfolio consisting of some 60 orphan and specialty pharmaceuticals Sweden


    Profile Country Notes
    Avlar Bioventures Ltd Venture investor in biotechnology and healthcare United Kingdom


    Profile Country Notes
    Excalibur Fund Managers Ltd United Kingdom

    Current and past shareholders

    Investor Contacts Round
    Avlar Bioventures Ltd
    Venture investor in biotechnology and healthcare
    +44 (1954) 211-515
    N/A
    Excalibur Fund Managers Ltd logo Excalibur Fund Managers Ltd
    +44 (20) 7887-7642
    N/A
    Swedish Orphan Biovitrum AB
    Swedish pharmaceutical company with a product portfolio consisting of some 60 orphan and specialty pharmaceuticals
    Acquisition